Non-Enzymatic Antioxidants against Alzheimer's Disease: Prevention, Diagnosis and Therapy.
Angelica VaresiLucrezia Irene Maria CampagnoliAdelaide CarraraIlaria PolaElena FlorisGiovanni RicevutiSalvatore ChirumboloAlessia PascalePublished in: Antioxidants (Basel, Switzerland) (2023)
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive memory loss and cognitive decline. Although substantial research has been conducted to elucidate the complex pathophysiology of AD, the therapeutic approach still has limited efficacy in clinical practice. Oxidative stress (OS) has been established as an early driver of several age-related diseases, including neurodegeneration. In AD, increased levels of reactive oxygen species mediate neuronal lipid, protein, and nucleic acid peroxidation, mitochondrial dysfunction, synaptic damage, and inflammation. Thus, the identification of novel antioxidant molecules capable of detecting, preventing, and counteracting AD onset and progression is of the utmost importance. However, although several studies have been published, comprehensive and up-to-date overviews of the principal anti-AD agents harboring antioxidant properties remain scarce. In this narrative review, we summarize the role of vitamins, minerals, flavonoids, non-flavonoids, mitochondria-targeting molecules, organosulfur compounds, and carotenoids as non-enzymatic antioxidants with AD diagnostic, preventative, and therapeutic potential, thereby offering insights into the relationship between OS and neurodegeneration.
Keyphrases
- oxidative stress
- cognitive decline
- reactive oxygen species
- mild cognitive impairment
- nucleic acid
- clinical practice
- hydrogen peroxide
- dna damage
- randomized controlled trial
- induced apoptosis
- cell death
- anti inflammatory
- small molecule
- cancer therapy
- systematic review
- drug delivery
- nitric oxide
- fatty acid
- signaling pathway
- endoplasmic reticulum
- bioinformatics analysis